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Abstract 
SOX8 is an HMG-box transcription factor closely related to SRY and SOX9. Deletion of the 
gene encoding Sox8 in mice causes reproductive dysfunction but the role of SOX8 in humans 
is unknown. Here, we show that SOX8 is expressed in the somatic cells of the early 
developing gonad in the human and influences human sex-determination. We identified two 
individuals with 46,XY disorders/differences in sex development (DSD) and chromosomal 
rearrangements encompassing the SOX8 locus and a third individual with 46,XY DSD and a 
missense mutation in the HMG-box of SOX8. In-vitro functional assays indicate that this 
mutation alters the biological activity of the protein. As an emerging body of evidence 
suggests that DSDs and infertility can have common etiologies, we also analyzed SOX8 in a 
cohort of infertile men (n=274) and two independent cohorts of women with primary ovarian 
insufficiency (POI; n=153 and n=104). SOX8 mutations were found at increased frequency in 
oligozoospermic men (3.5%; p<0.05) and POI (5.06%; p=4.5x10
-5
) as compared to 
fertile/normospermic control populations (0.74%). The mutant proteins identified altered 
SOX8 biological activity as compared to the wild-type protein. These data demonstrate that 
SOX8 plays an important role in human reproduction and SOX8 mutations contribute to a 
spectrum of phenotypes including 46,XY DSD, male infertility  and 46,XX POI. 
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Introduction 
Human sex determination is a tightly controlled and highly complex process, where the 
bipotential gonad anlage develops as one of two mutually antagonistic fates – the ovary or a 
testis. SRY is well-established as the primary testis determining gene on the Y chromosome. 
In the XY gonad, SRY acts during embryonal development to upregulate the downstream 
effector SOX9 beyond a critical threshold, which promotes testis development and in turn 
represses “ovarian pathways” in the male gonad through multiple mechanisms [1,2]. In mice, 
up-regulation of Sox9 in males is by the synergistic action of Sry with Nr5a1 (also known as 
Steroidogenic factor-1 (Sf1)), through binding to multiple elements within a testis-specific 
Sox9 enhancer (Tesco) [1]. Sox9 expression is required to establish Sertoli cell identity in the 
developing testis [2]. Once formed, foetal Sertoli cells produce anti-Müllerian hormone 
(AMH) and coordinate the cellular and morphogenetic events leading to primary sex 
determination [2].  
 
Although the SOX genes SRY and SOX9 play essential roles in driving early mammalian 
testis-determination, emerging evidence suggests the contribution of another Sox gene, Sox8, 
in murine testis-determination as well as in the maintenance of gonadal function. Sox8 shows 
an overlapping expression pattern with Sox9 in foetal and adult mouse gonad and functional 
redundancy between Sox8 and Sox9 occurs during testis development [3-6]. Sox8 XY null 
mutants show normal testis development but develop postnatal progressive spermatogenic 
failure [7].  
 
Development and maintenance of the mammalian gonad is regulated by a double repressive 
system, where an equilibrium of mutually antagonistic pathways must be attained for normal 
development of either the testis or ovaries. [2-6]. In humans, changes in this delicate balance 
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can lead to Disorders of (or Differences in) Sex Development (DSD), which are defined as 
congenital conditions with discordant development of chromosomal, gonadal or anatomical 
sex [8].
  
The incidence of DSD has been estimated at 1:2,500 to 1:5,000 births [9-10]. 
Excluding inborn errors in steroidogenesis, a molecular diagnosis will be reached in only 20% 
of all individuals with 46,XY DSD [9]. Around 40% of the cases with 46,XY complete 
gonadal dysgenesis (CGD) can be explained by mutations involving three genes SRY, NR5A1 
and MAP3K1 [4,5]. Pathogenic variants in other sex-determining genes such as CBX2, 
GATA4 or FOG2/ZFPM2 are found in a very small percentage of cases [9, 10].
 
Hence, the 
aetiology in majority of the individuals with DSD remain poorly understood. 
 
An emerging body of evidence suggests that DSD and infertility can have common 
aetiologies, For example, mutations involving NR5A1 (SF-1), a key player in many aspects of 
reproductive function including sex-determination, are associated not only with a spectrum of 
DSD such as 46,XY CGD, 46,XY undervirilised males with testes, or 46,XX (ovo)testicular 
DSD but also more prevalent forms of human infertility, i.e. 46,XY men with spermatogenic 
failure and 46,XX women with primary ovarian insufficiency (POI) [11-14]. Human 
infertility is a major human health issue; one in seven couples worldwide have problems 
conceiving and both men and women are affected equally [15,16]. POI is characterised by 
primary or secondary amenorrhea, high gonadotropin levels (FSH above 40iU/l on two 
occasions at least a month apart) and estrogen deficiency in women under the age of 40 years 
[17]. Male infertility includes azoospermia characterized by complete absence of spermatozoa 
in the ejaculate, whereas oligozoospermia is defined as sperm concentrations below the World 
Health Organization reference level of 15 × 10
6 
sperm/ml [18]. The underlying basis for either 
male or female infertility is complex, including both physiological and environmental factors 
as well as gene mutations. Although mouse models have revealed hundreds of genes that are 
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associated with fertility, only a few single-gene defects that cause male and/or female 
infertility have been identified in humans [12,13,19-24].  Here, for the first time we 
demonstrate that mutations involving the human SOX8 gene are associated with a range of 
phenotypes including 46,XY DSD as well as male infertility and ovarian insufficiency in 
females. 
 
Results 
Rearrangements involving the SOX8 locus and 46,XY DSD. Patient 1 is a phenotypic 
female who presented at the age of 27 years with primary amenorrhea (Patient 1, Table 1).  
Chromosome analysis showed a 46,XY karyotype with a paracentric inversion 
(46,XY,inv(16)(p13.3p13.1); Fig. 1A, 1B), which was confirmed by FISH analysis (Fig. 1C). 
Her parents and unaffected sister were not available for analysis.  Hence, it is unknown if this 
rearrangement is de novo, however this rearrangement has not been reported in control 
databases. Array-CGH did not reveal any chromosomal imbalances, including the chr16 short 
arm, associated with the phenotype. The centromeric breakpoint was mapped within the BAC 
clone RP11-609N14 (chr16:10428838-10600163) (Fig. 1D). The telomeric breakpoint was 
mapped within the BAC clone RP11-728H8 between chr16;814190-962809 (Fig. 1E). Whole 
genome sequencing confirmed these results and indicated a centromeric breakpoint at 
chr16:10522104-10522114 and a telomeric breakpoint at chr16:881929-881965. The 
transcription initiation site of the SOX8 gene is at chr16:1031808. Therefore, the breakpoint is 
located ~150 Kb upstream of SOX8 (Fig. 1A). A bilateral gonadectomy revealed two small 
gonads, which on histological examination showed two streak-like gonads with no germ cells 
or differentiated tissue (Fig. 2A).  
Patient 2 is a 46,XY girl with mild post-natal anaemia, sleepiness, poor feeding and 
tachycardia (Patient 2, Table 1 and Supplemental information). Physical examination showed 
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a prominent forehead and ophthalmological evaluation revealed small bilateral chorioretinal 
colobomas. At birth the genitalia consisted of a midline clitorophallic structure with bilateral 
labioscrotal folds, which were fused at the midline. On pelvic ultrasound, there was no uterus 
or vagina noted and gonads and epididymides were identified in the labia bilaterally. Pituitary 
hormone levels were within normal limits. The child was assigned male and at 10 months of 
age underwent the first stage of surgery for hypospadias, chordee repair and posterior urethral 
mobilization, and scrotoplasty. At 2 yrs 10 months the patient underwent bilateral 
orchidopexy, bilateral inguinal hernia repair, and bilateral gonadal biopsy. Gonadal histology 
showed seminiferous cords, variable germ cells and reduced Leydig cell numbers by 
Calretinin staining (Fig. 2B-E). aCGH detected a two copy DNA gain in the 16p13.3 region 
(arr[h19] 16p13.3(137893-992302)x4, log2=+1), spanning at least 854 kb (Fig 1F), resulting 
in tetrasomy of that DNA segment. This region comprises at least 27 genes, including the α-
globin gene cluster (S1 Table). FISH analyses using RP11-598I20 BAC probe on cultured 
peripheral blood samples from the patient and both parents indicated that the tetrasomy was a 
de novo event (Fig. 1G, 1H). The centromeric breakpoint of this triplication was located 
within the intron 2 of the LMF1 (lipase maturation factor 1) gene, ~39.5 kb upstream of the 
SOX8 gene. Homozygous, loss-of-function LMF1 gene mutations are responsible for 
hypertriglyceridemia and decreased lipase activity and hence this gene was not considered to 
be associated with the phenotype [25]. Interestingly, SOX8-specific enhancer elements are 
included in the triplication [26]. Together these data suggest that rearrangements at the SOX8 
resulting in dysregulation of SOX8 expression could negatively impact testis-determination 
and may result in 46,XY DSD including disorders of testis-determination. Consistent with 
this postulation, we observed that SOX8 is co-expressed with NR5A1 and SOX9 in the early 
stages of human testis-determination in Sertoli cells and Leydig cells as well as in Sertoli and 
Leydig cells in adult men (Fig. 3A, S1 Fig). Single cell RNA sequencing on XY mouse 
Downloaded from https://academic.oup.com/hmg/advance-article-abstract/doi/10.1093/hmg/ddy037/4823478
by Sandra Angus user
on 29 January 2018
 9 
gonads during sex determination has also demonstrated that Sox8 is co-expressed with other 
genes involved in sex-determination including Nr5a1, Dmrt1 and Gata4 [27]. 
 
A missense mutation in the HMG-box domain of SOX8 is associated with a lack of testis-
determination. Based on the above observations, we extended the SOX8 mutation screen to a 
large cohort of 46,XY DSD individuals (Table 2). Three heterozygous missense SOX8 
variants were identified in a screen of 204 cases of unexplained 46,XY DSD. Two of these 
changes were observed in the control cohort and their contribution to the phenotype is 
considered unlikely. The third mutation, a heterozygous c.468G>C p.Glu156Asp amino acid 
substitution was identified in a 46,XY phenotypic female who presented at 16 years of age 
with primary amenorrhea (Patient 3 Table 1, Fig 4A). The Glu156 residue is located in the 
HMG-box and is evolutionarily conserved not only within the SOX8 protein but also in other 
members of groups E and F SOX protein family (Fig. 4B). The mode of inheritance of this 
mutation is unknown as the parents were unavailable for study. This mutation was not 
observed in our control cohort, but it is present as a rare variant in the ExAC database 
(2:121,228 alleles, rs764098477). The SOX8 p.Glu156Asp mutation is not expected to disrupt 
DNA binding per se because this residue does not map to the DNA interaction interface (Fig 
4C. Furthermore, exchanging the equivalent residues in Sox2 (Sox2Lys to Glu) and Sox17 
(Sox17Glu to Lys) are reported not to show any effect on DNA binding by the SOX HMG 
box in the absence of partner proteins [28]. However, this mutation could affect how SOX8 
dimerizes with its partner factors on DNA, since changing the same residue in Sox2 and 
Sox17 affected the ability of these proteins to interact with OCT4 (Fig. 4C [28].  
 
A series of in-vitro analyses were performed to assess the effect of this mutant on the 
biological activity of the SOX8 protein. Transient transfection assays were performed since a 
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number of SOXE group-responsive genomic elements have been identified that, when placed 
upstream of a reporter gene, can be used to quantitate transcriptional regulatory function of 
protein variants [29].  The function of SOX genes involves a complex interaction with many 
other transcriptional co-regulators, including other SOX proteins [29] and therefore we 
considered that the consequence of the SOX8 mutation may be promoter or cell context 
dependent. Our data show that the mutant SOX8 protein exhibits a context-specific loss-of-
function activity. The WT-and mutant SOX8 proteins can activate a series of gonadal 
promoters (Fig. 5A). However, the SOX8p.Glu156Asp specifically fails to synergize with 
NR5A1 to transactivate the Sox9 Tesco enhancer element (Fig. 5A), yet both WT-SOX8 and 
SOX8p.Glu156Asp proteins physically interact with the NR5A1 protein (Fig. 6, S2 Fig). The 
mutation also impacted on the functional interaction between SOX8 and SOX9. Both SOXE 
proteins have the ability to heterodimerize and combinatorially regulate their target gene 
expression [30, 31]. We show that the WT-SOX8 protein binds to SOX9, however the 
SOX8p.Glu156Asp protein cannot (Fig. 6, S2 Fig). The SOX8p.Glu156Asp mutant also 
exerts a repressive effect by negatively affecting the synergistic activation of the Tesco 
enhancer by NR5A1 and SOX9 (Fig. 5B). Finally, the SOX8p.Glu156Asp protein also has a 
dominant negative effect on the WT-SOX8 protein since it reduced, in a dose-dependent 
manner, the synergistic activation of the Tesco reporter by WT-SOX8 and NR5A1 (S3 Fig). 
All these results are consistent with the hypothesis that the mutant SOX8 protein has an 
altered biological activity impairs testis-determination 
 
SOX8 mutations associated with human infertility. To investigate whether mutations in 
SOX8, like NR5A1, could also contribute to a wider spectrum of male and female infertility, 
we sequenced the coding region of SOX8 in 427 men and women with infertility. The 
incidence of mutations in the control cohort of fertile and/or normospermic men was 0.74%. 
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In contrast, rare or novel SOX8 variants were observed in 1.47% of azoospermic men, 3.5% 
of oligozoospermic men (p=0.0151, Fishers t-test, 2-tailed) and 9/153 women with POI in an 
initial cohort (5.9%; p=0.000107) and in 4/104 (3.85%; p=0.0191) of women with POI in a 
replication cohort (Tables 2 and 3). Combining the data from both cohorts, we found a 
significant association of mutations in SOX8 with POI (5.06%; p=4.5x10
-5
).  
 
The majority of mutations associated with infertility flank the HMG-box and fall within one 
of the two transactivation domains. Although many of these missense mutations are predicted 
by computational methods to have a deleterious effect on protein function, the interpretation 
of the significance of mutations in human disease remains very challenging. We therefore 
sought to test the consequence of the SOX8 mutations associated with infertility in a series of 
functional assays. As expected, the transient transfection assays using the AMH, Dmrt1 and 
NR5A1 promoters as reporters in HEK 293-T and mES cells indicated biological differences 
between mutated wild-type proteins that, in some cases, were promoter specific, e.g. the 
p.Asp382Asn mutation shows a specific loss-of-function with the AMH promoter (S4 Fig). 
Furthermore, some mutant proteins show changes in cellular localization (S5 Fig).  
 
Although, a contribution of Sox8 to male infertility in the mouse has been established for 
some time, the finding of an association between human POI and SOX8 variants is a novel 
finding since Sox8
-/-
 female mice are fertile [7]. We therefore sought to examine the profile of 
SOX8 expression in the human ovary to see if this is consistent with a role for mutations in 
the protein contributing to female infertility. We observed that the SOX8 protein is expressed 
in the 40 week foetal ovary and in the adult ovary (Fig. 3B and S1 Fig). The SOX8 protein is 
highly expressed in granulosa cells at both stages. 
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Discussion 
Our data provide the first evidence that SOX8 plays a role in human sex-determination and in 
the function of the adult gonad. Mouse models also suggest that Sox8 plays a key role in early 
testis-determination as well as maintaining male fertility. We identified three patients with 
46,XY DSD who carried rearrangements/mutations involving the SOX8 gene.  
 
One patient had a paracentric inversion with a breakpoint ~150 Kb upstream of the SOX8 
gene. The only other gene within the region is LMF1. Since, homozygous, loss-of-function 
mutations in the LMF1 gene are associated with hypertriglyceridemia and decreased lipase 
activity, this gene was not considered to be responsible for the phenotype [25].  
 
A second patient carried four copies of an 854 Kb region immediately 5` to the SOX8 gene 
including SOX8 enhancer elements as well as the α-globin gene cluster [26]. Duplication of α-
globin genes is a rare cause of anaemia that may lead to imbalances of α- and β-chains in 
haemoglobin tetramer, especially in β-thalassemia carriers [32, 33]. Alternatively, the 16p13.3 
chromosomal rearrangement may result in disruption of the long-range regulation leading to a 
partial silencing of genes expression consistent with prenatal and postnatal anaemia observed 
in patient 2 [34]. The other somatic anomalies seen in this patient may be a result of gene 
dosage of one or more of the other genes located in the duplicated region (Table S1). Indeed, 
a patient with 46,XY gonadal dysgenesis, skeletal and cardiac anomalies and developmental 
delay was reported to carry a similar 560 kb duplication located approximately 18 kb 
upstream of SOX8 [35]. These rearrangements at the SOX8 locus may cause dysregulation of 
SOX8 expression. This hypothesis is consistent with the multiple reports of 46,XY gonadal 
dysgenesis associated with chromosomal rearrangements even up to several Mb upstream of 
genes involved in sex-determination including SOX9 and NR0B1 [36-39]. Furthermore, the 
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centromeric breakpoint in patient 2 falls between the conserved E1 and E2 SOX8 enhancer 
elements, which are required for murine Sox8 gene expression [26]. Dysregulation of SOX8 
expression could negatively impact on male gonadal development and lead to various degrees 
of 46,XY DSD. Indeed, 46,XY individuals carrying deletions that include SOX8 (ATR16 
syndrome) occasionally present with mild anomalies such as hypospadias or cryptorchidism 
and Patients 1 and 2 may represent part of this broad DSD spectrum [40].  
 
The third patient presenting with 46,XY gonadal dysgenesis had a missense mutation 
involving a highly conserved glutamic acid residue within helix 3 of the SOX8 HMG-box. 
The severe gonadal phenotype in this patient, which is due to lack of appropriate testis-
determination, may be due to the specific dominant negative activity of the 
SOX8p.Glu156Asp protein on the WT-SOX8 protein and/or the repressive effect of this 
mutant protein on SOX9/NR5A1 synergy at the Sox9 Tesco enhancer that we observed using 
in-vitro assays (Fig. 7).  These data, which provide evidence for a role of SOX8 in early 
human testis development are supported by murine studies. The absence of both Sox9 (pro-
testis) and Rspo1 (pro-ovary) in XX foetuses results in the development of ovotestes and 
hypoplastic testis [4]. SoxE group genes, Sox10 and Sox8 that are normally repressed by 
Rspo1, are activated in the double knockout gonads, suggesting that Sox8 may serve as a 
driver of testis formation in the absence of Sox9 [4]. Recent data suggest that Sox8 may also 
be involved in repressing the ovarian pathway, via the repression of Foxl2 expression during 
early testis formation [41]. 
 
In this study we have also identified mutations in SOX8 associated with cases of male and 
female infertility. Although the mechanism(s) leading to infertility in either sex is unclear, all 
mutations associated with infertility showed differences in biological activity compared to the 
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WT protein and all mutations flank the HMG-box. Transient transfection assays using as a 
target the promoters of genes important for gonad function showed a wide range of effects 
including promoter specific loss-of-function or alterations in the cellular localization of the 
mutated protein. Inferring precisely how these mutations cause infertility is difficult since the 
gene regulatory pathways downstream of SOX8 have not been defined in either the XY or 
XX gonad. In mice Sox8 is essential for the maintenance of male fertility beyond the first 
wave of spermatogenesis [10]. At 5 months of age Sox8
-/-
 mice show a progressive 
degeneration of the seminiferous epithelium through perturbed physical interactions between 
Sertoli cells and the developing germ cells [10]. Here, we identified rare or novel SOX8 
mutations in 3.5% (p<0.05) of men with unexplained reduced sperm counts as compared to a 
frequency of 0.78% in ancestry-matched normospermic/fertile control cohorts. It is important 
to compare our data with a cohort of individuals who are known to be fertile and/or 
normospermic since infertility is a common phenotype and public databases, such as ExAC, 
are likely to contain a background pool of rare variants that can cause infertility and/or DSD. 
These cases of male infertility may represent mild forms of testicular dysgenesis or, similar to 
the mouse model the SOX8 protein may also be a regulator of Sertoli–germ cell adhesion 
independently of its role in primary testis-determination [10]. 
 
Our analyses also revealed mutations in SOX8 in 5.06% of all women with POI from two 
replication studies (p=4.5x10
-5
). This suggests that mutations in human SOX8 may have a 
greater impact on ovarian rather than testis function. Although Sox8
-/-
 female mice are fertile, 
Sox8 expression has been reported in preantral follicles, preovulatory follicles, cumulus 
granulosa cells and at high levels in mural granulosa cells, which line the wall of the follicle 
and are critical for steroidogenesis and ovulation [7, 42]. We have shown that SOX8 protein 
is expressed specifically in the granulosa cell of the developing and adult ovary in the human. 
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The observation that Sox8 expression is higher in the mural cells that line the follicle wall 
than in the cumulus cells that surround the oocyte suggests that SOX8 may play a role in 
granulosa cell differentiation [42]. We can hypothesize that in female, in the absence of 
SOX9, SOX8 may be an important regulator of AMH expression (required for maintenance of 
the germ cell pool) in the adult ovary and, therefore, mutations in SOX8 may result in POI.   
 
The results presented in this study provide novel insight into the genetic mechanisms of 
human gonadal development and function and provide further evidence that a spectrum of 
reproductive phenotypes from DSD to infertility can be associated with variations in a single 
genetic factor.  
 
Materials and Methods 
Detailed study methods are provided in SI Methods 
Subjects and Samples. All patients with 46,XY DSD met the revised criteria of the Pediatric 
Endocrine Society (LWPES)/European Society for Paediatric Endocrinology (ESPE). This 
study was approved by the local French ethical committee (2014/18NICB – registration 
number IRB00003835) and consent to genetic testing was obtained from adult probands or 
from the parents when the patient was under 18 years.  Patient ancestry was determined by 
self reporting, based on responses to a personal questionnaire, which asked questions 
pertaining to the birthplace, languages and self-reported ethnicity of the participants, their 
parents and grandparents. Genes known to be involved in 46,XY DSD were screened for 
mutations in the XY DSD cohort and high resolution aCGH was performed on all cases and 
indicated normal ploidy in all cases. An extended description of patient 2 is provided in SI 
Methods. The infertile male population consisted of 274 men of European or North African 
ancestry. For each man ejaculates were obtained by masturbation after 2–7 days of sexual 
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abstinence. All underwent an andrological work-up, which included medical history, physical 
examination, hormonal evaluation (FSH, LH, and testosterone) and semen analysis. Men with 
known clinical (cryptorchidism, infections, varicocele) or genetic (karyotype anomalies, Y 
chromosome microdeletions) causes of infertility were excluded. Oligozoospermia was 
defined as having less than 15x10
6
 sperm/ml. Primary amenorrhea was diagnosed when 
pubertal development was absent despite the patient being of pubertal age (greater than 13 
years) with increased basal plasma FSH concentration (>9 IU/L). Cases of secondary 
amenorrhea (no menstruation after 6 cycles) and premature ovarian failure (amenorrhea, 
hypoestrogenism, and elevated serum gonadotropin levels in women younger than 40 years of 
age) were included. 
 
The control panel consisted of 280 unrelated normospermic 46,XY males of French ethnic 
origin with known fertility and no history of testicular anomalies (determined by self-
reporting) from the Biobank for Research on Human Reproduction (GERMETHEQUE). An 
additional in-house 180 normospermic men and 130 fertile men of Arab/North African 
ancestry were included as controls. European ancestry-matched in-house controls of known 
fertility status were also included (n=20). Other control populations included fathers of 
European ancestry from the 1000 genomes project (Iberian and Northern Europeans from 
Utah, n=103), the Danish Genome Project (n=50) and from the University of Dundee (n=50). 
 
Genomic analysis. Chromosome analysis, ArrayCGH, genomic, exome and Sanger 
sequencing are all described in SI Materials and Methods. 
 
Immunohistochemistry. Human fetal testis tissue (9 weeks post conception) was provided 
with approval from the Human Developmental Biology Resource (HDBR, www.hdbr.org). 
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Term fetal (40 weeks) ovary was obtained from Abcam (#ab4412) and adult ovary tissue (19 
years) was obtained from Tissue Solutions. Tissue sections (12 µm) were fixed briefly in 4% 
PFA in TBS, rinsed in TBS and blocked in 1% BSA in TBS-Tween (0.5% Tween) for 1 hour 
before incubating overnight with rabbit monoclonal SOX8 antibody (Sigma HPA41640; 
1:200 dilution) and, where relevant, mouse monoclonal NR5A1 (SF1) antibody (Thermo 
Fisher #434200; 1:200 dilution). Sections were washed in TBS-Tween and incubated for 1 
hour with the relevant secondary antibodies: Alexa555 goat anti-rabbit (Invitrogen, A21429; 
1:400) and Alexa488 goat anti-mouse (Invitrogen, A11001; 1:400). Nuclei were 
counterstained with DAPI (Sigma). Slides were washed and mounted using ProLong Gold 
Antifade Mountant (Lifetech, #P36930). Images were collected on a Zeiss LSM 710 confocal 
microscope (Carl Zeiss) and analyzed using Zeiss Zen 2009 and Image J. 
 
Details of the plasmids, cells lines, cellular localization assays, structural modelling and 
co-immunopreciptation are provided in the SI Methods  
 
Statistics. The results of the luciferase assays were compared for their statistical significance 
by calculating two-tailed Student’s t Test using GraphPad Prism software. 95% confidence 
interval was calculated using the mean difference between the two groups being tested.  The 
data for each of the groups tested and their t values, along with degrees of freedom (df), 
standard error of difference, P-values and predicted statistical significance are summarized in 
S2 Table. Based on the P-values the GraphPad Prism software calculates the difference as not 
significant, not likely to be significant, significant, very significant and extremely significant. 
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Figure Legends 
Figure 1 Chromosomal rearrangements at the SOX8 locus associated with 46,XY DSD. 
(A) Schematic representation of the 16p inversion in patient 1 indicating the genes and clones 
of the region and the position of the telomeric breakpoint (TB) and centromeric breakpoints 
(CB). The position of the transcription initiation site of the SOX8 gene is indicated 
(chr16:1031808), the Sox8 enhancer elements (E1-E4) and the position of the BACs used for 
FISH analysis. Patient 1 with (B) GTG banding showing the rearranged chromosome 16 
(arrow). (C) FISH on metaphases with BAC RP11-161M6 (green; chr16:991,108-1,141,991- 
UCSC Genome Browser; GRCh37/hg19) and RP11-297M9 (red; chr16:9,727,655-9,920,250) 
confirming the paracentric inversion (arrow). (D) The CB is located within the clone, RP11-
609N14 on 16p13.13). (E) The TB mapped within RP11-728H8, on 16p13.3 (arrows). Patient 
2 (F) Chromosome 16p rearrangement.  The aCGH profile indicated an 854 kb triplication in 
the 16p13.3 region. Affected region is indicated by a blue bar. Red rectangles outline the 
triplication breakpoints. A magnified view of the triplication breakpoints shows, on the left, a 
CB located in the intron 1 of the NPRL3 gene. The 16p13.3 triplication starts at chr16:137893 
position and spans proximally including the α-globin genes (HBZ, HBM, HBA1, HBA2, and 
HBQ1) and their upstream cis-regulatory elements R1-R4 (red bars).  On the right, the TB of 
the triplication (chr16:992,302) is located ~39.5 kb upstream of the SOX8 gene. The SOX8-
specific enhancers are mapped within the triplicated segment. Genes are indicated by black 
arrows with vertical lines specifying exons. Arrows correspond to a direction of gene 
transcription. (G) Interphase FISH analysis using RP11-598I20 (16p13.3, labeled red) and a 
control RP11-121O8 (16p13.1, labeled green) probe showing a triplication (white arrow) in 
the patient 20. (H) Representative FISH image using the same probes shows a normal 
hybridization pattern observed in both parents  
 
Downloaded from https://academic.oup.com/hmg/advance-article-abstract/doi/10.1093/hmg/ddy037/4823478
by Sandra Angus user
on 29 January 2018
 27
Figure 2. Gonad histology of Patients 1 and 2.  Patient 1, (A) Ovarian-like stromal cells 
with no evidence of testicular tissue consistent with 46,XY complete gonadal dysgenesis. 
Patient 2, (B) Seminiferous tubules (cords) are mildly contorted in places (black arrow) and 
some are misshapen.  The interstitium space is expanded and mildly fibrotic (white arrow; 
H&E; 200X).  (C) Immunohistochemistry for calretinin shows only focal Leydig cells 
(arrows; calretinin stain, blue; 200X). (D) Inhibin immunohistochemistry highlights Sertoli 
cells, making the contorted tubules more evident (inhibin; 200X).  (E) Immunohistochemistry 
for SOX9 staining the nuclei of Sertoli cells within tortuous tubules (SOX9; 200X).  
 
Figure 3. Expression of the SOX8 protein in human gonad tissues. (A) The SOX8 protein 
(red) is expressed in the human male Sertoli and Leydig cells together with NR5A1 (green) 
during early testis formation (image at 9 weeks post conception). Primitive seminiferous 
cords are indicated by the dashed lines (B) The SOX8 protein expression in the granulosa 
cells of the late fetal ovary (image at 40 weeks of gestation). (C) Immunohistochemistry 
showing SOX8 expression in granulosa cells (arrow) lining the follicles of the adult ovary (19 
yrs old; scale bars are 50 µm).  
 
Figure 4. Mutation in the HMG-box of SOX8 associated with 46,XY gonadal dysgenesis. 
(A) Schematic representation showing important functional domains of the SOX8 protein. 
The amino acid sequence of the HMG domain including the three alpha-helices, the two 
nuclear localization signals (NLS1, NLS2), and the nuclear export sequence (NES) together 
with the position of SOX8p.Glu156Asp (p.E156D) mutation are indicated. The DNA-
dependent dimerization domain (DIM), the DNA-binding HMG domain, and the 
transactivation domains (TA1, TA2) are shown. (B) Left, alignment of the C-terminal of the 
SOX8 HMG-box domain containing helix 3 from selected vertebrates. Right, the alignment of 
Downloaded from https://academic.oup.com/hmg/advance-article-abstract/doi/10.1093/hmg/ddy037/4823478
by Sandra Angus user
on 29 January 2018
 28
the distal portion of the SOX8 HMG-box domain with other human SOXE and SOXF family 
members. The position of the p.Glu156Asp missense mutation is highlighted. (C) Structural 
models for ternary complexes of conjectured SOX8p.Glu156Asp -SOX8, SOX8p.Glu156Asp 
-SOX9 and SOX8p.Glu156Asp -OCT4 dimers on composite DNA elements. SOX8 is shown 
in dark red, SOX9 in orange and OCT4 in blue. The HMG domains of SOX E proteins and 
the POU domain of OCT4 are shown as cartoon with cylindrical alpha-helices and the DNA 
as gray van-der-Waals surface. The SOX8p.Glu156Asp site is drawn as ball-and-sticks. The 
DNA sequences used to generate the models with color-coded binding elements are depicted 
underneath the models. The SOXE HMG box is N-terminally extended by a 40 amino acid 
dimerization (DIM) domain of unknown structure that mediates highly cooperative DNA 
dependent dimerization presumably by interactions with the HMG box. 
 
Figure 5. SOX8p.Glu156Asp shows altered biological activity. (A) The transcriptional 
activities of WT-SOX8 and SOX8p.Glu156Asp were studied using the human AMH and 
NR5A1 promoters, mouse Dmrt1 promoter and the Sox9 Tesco enhancer as reporters, 
following transfection in HEK293-T cells. The data shown represent the mean ± SEM of 
minimum three independent experiments, each of which was performed at least in 
quadruplicate. The reporter constructs were transfected into HEK293-T cells with either the 
WT-SOX8 or SOX8p.Glu156Asp expression vector. The results are expressed as relative 
percentage of WT-SOX8 activity (100%). The SOX8p.Glu156Asp can activate the gonadal 
promoters in a similar fashion to WT-SOX8. However, although SOX8p.Glu156Asp can 
synergistically activate the AMH promoter with NR5A1, it fails to synergise with NR5A1 to 
activate the Sox9 Tesco enhancer. (B) HEK 293-T cells were co-transfected with Tesco 
reporter construct (10ng), WT-NR5A1 (1ng) and WT-SOX9 (1ng) and increasing amount of 
WT-SOX8 or SOX8p.Glu156Asp (0,1,2,5,10 ng). Results are expressed as Relative 
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Luminescence Units (RLU). The SOX8p.Glu156Asp mutant exerts a repressive effect by 
preventing synergistic activation of the Sox9 Tesco enhancer by NR5A1 and SOX9 even at 
three times lower concentrations. 
 
Figure 6. Protein-Protein interaction assayed using Proximity ligation assay. Plasmids 
encoding SOX8-WT or SOX8p.Glu156Asp were transiently expressed with WT-NR5A1 or 
SOX9 for 48hrs in HEK293T cells. Protein-protein interaction of SOX8-WT and 
SOX8p.Glu156Asp with NR5A1 and SOX9 were analysed using the Duolink proximity 
ligation assay. Nuclei are stained with DAPI (blue) and Duolink signal representing 
interaction between the proteins is shown in green. Each green dot represents a single 
dimerization event. Both the SOX8-WT and SOX8p.Glu156Asp proteins can physically 
interact with NR5A1. Whereas, although SOX8-WT protein can interact with SOX9, the 
SOX8p.Glu156Asp cannot. 
 
Figure 7. Schematic representation of the results of the in vitro assays for the 
SOX8p.Glu156Asp protein. (A) The mutant SOX8 protein has the ability to physically 
interact with the NR5A1 protein but in contrast to the WT-SOX8 protein does not synergize 
with NR5A1 to promote reporter gene activity using the Tesco enhancer as a target. (B) The 
mutant SOX8 protein does not physically interact with the SOX9 protein and shows a lack of 
synergy with SOX9/NR5A1 to promote reporter gene activity. (C) The SOX8 mutant protein 
also shows dominant negative activity by impairing promoter gene activity of the WT-SOX8 
protein in synergy with NR5A1.  
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Table 1. Phenotypes, genetics and clinical investigations of 46,XY DSD with mutations involving the SOX8 locus (patients 1 and 2) or 
gene (patient 3). 
 
 
CGD: complete gonadal dysgenesis; PGD: partial gonadal dysgenesis; FSH: Follicle stimulating hormone; LH: Luteinizing hormone. All 
mutations are heterozygous. 
 
 
 
 
 
Patient Phenotype Clinical presentation 
(age) 
Genetics Hormonal profile  
(normal range) 
Genitalia and gonads Diagnosis 
1 Female  
 
Primary amenorrhea 
with female external 
genitalia  
 
46,XY,inv(16)(p1
3.3p13.1)  
  
FSH: 59.5 iU/l (2.0–
15.0) 
LH: 23.6 iU/l (2.1–14.9) 
T: 0.7 ng/ml (2.70–9.00) 
Bilateral streak gonads with fallopian tubes. 
Stromal-like tissue with no evidence for testicular 
tissue or follicles. 
Small immature uterus, 43x22x30 mm (27 yrs). 
46,XY CGD  
2 Female at 
birth then 
changed to 
male 
assignment 
Ambiguous genitalia 
(birth), mild anemia, 
skeletal anomalies, 
mild developmental 
delay 
46,XY 
arr[h19] 
16p13.3(137,893-
992,302)x3 
FSH: 2.31 iU/l (0.16-4.1 
mIU/ml) 
LH: 17.35 iU/l (0.02-7.0 
mIU/ml) 
T: 1.38 ng/ml (0.6-4 
ng/ml) 
DHT 36 ng/dL (12-85) 
At birth clitorophallic structure (1x1cm) with 
urethral meatus at base. Fused labioscrotal folds 
with palpable gonads (R: 1.2x0.6x0.8cm, L: 
1.1x0.4x0.7cm). No uterus or vagina. Testis 
histology showed seminiferous tubules, variable 
germ cells and reduced Leydig cell numbers. 
46,XY severe 
undervirilization 
3 Female Primary amenorrhea 
(16 yrs)  
46,XY SOX8 
p.Glu156Asp 
PolyPhen2 Score 
0.999 
Elevated FSH, LH: 
undetectable T levels  
Bilateral streak gonads with absent uterus. 
Epididymis-like structure present. 
46,XY PGD  
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Table 2. SOX8 mutations in 46,XY DSD, male infertility, primary ovarian insufficiency and in the control cohort of ancestry-matched 
fertile/normospermic individuals 
 
46,XY DSD 
(n=204) 
Azoospermia 
(n=131) 
Oligozoospermia 
(n=143) 
POI 
(n=153) 
POI 
replication 
study (n=104) 
Fertile and/or normospermic controls (n=813; 
European ancestry 503; North African/Arab ancestry 
310) 
p.Glu156Asp p.Lys241Thr p.Gly359Arg (x2) p.Arg8_Ser9del 
deletion of 2 AA 
p.Pro11Leu 
 
p.Ala240Thr1 
 
p.Pro336Leu p.Asp382Asn p.Ala373Ser p.Ala32Val p.Pro196Leu p.Thr331Met2 
p.Thr340Ser  p.Gly378Ser p.Pro242Leu (x2, 
sisters) 
p.Pro242Leu p.Pro336Leu3 
  p.Asp382Asn p.Ser267Leu p.Ala416Thr p.Thr340Ser3 
   p.Val282Ile  p.Ala373Thr1 
   p.Asp382Asn (x3)  p.Ala428Thr3 
   p.Ala416Thr   
1.47% 1.53% 3.5%a 5.9%b 3.85%c 0.74% 
 
a
p=0.0151, 
b
p=0.000107, 
c
p=0.0191 compared to controls (Fishers t-test, 2 tailed). POI: Primary ovarian insufficiency; DSD: Disorder of Sex 
Development; AA: Amino acids. All mutations are heterozygous. Fertile fathers from 
1
1000 genomes project (European ancestry), 
2
Danish 
Genome Project and 
3
in-house controls. 
 
 
 
 
 
 
 
Downloaded from https://academic.oup.com/hmg/advance-article-abstract/doi/10.1093/hmg/ddy037/4823478
by Sandra Angus user
on 29 January 2018
 33
Table 3. Mutations in the SOX8 gene associated with human male or female infertility. Heterozygous missense mutations were identified in the AIRE 
and NR5A1 genes in cases 18 and 20 respectively. In such cases the SOX8 mutation may contribute to the severity of the phenotype.  *Novel variant. POI, primary ovarian 
insufficiency. All mutations are heterozygous. 
 
Patient Mutation Variant 
identifier 
Global minor 
allelic frequency  
PolyPhen2 
Score 
Ancestry Phenotype and comments 
4 p.Lys241Thr rs553836905 0.0002 0.762 European Azoospermia 
5 p.Gly359Arg rs199719055 0.000014 0.961 Eastern European Oligozoospermia 3.4x10
6
/ml 
6 p.Gly359Arg rs199719055 0.000014 0.961 French Oligozoospermia 2x10
6
/ml 
7 p.Ala373Ser rs200828189 0.0036 0.000 French Oligozoospermia 9x10
6
/ml 
8 p.Gly378Ser rs576173763 0.0064 0.004 Senegalese Severe oligozoospermia 0.005x10
6
/ml 
9 p.Asp382Asn rs143203270 0.0057 0.986 Tunisian Oligozoospermia. 6x10
6
/ml 
10 p.Asp382Asn rs143203270 0.0057 0.986 Algerian Azoospermia 
11 p.Arg8_Ser9del* - - - Italian POI. Menarche at 13 yrs; one pregnancy; secondary amenorrhea and 
POI at 37 yrs. Mother had menopause at 35 yrs  
12 p.Pro11Leu rs200231150 0.010 0.636 European POI. Primary amenorrhea 
13 p.Ala32Val* - 0.000009  0.919 Italian POI. Menarche at 14 yrs; secondary amenorrhea and POI at 21 yrs 
14 p.Pro196Leu - 0.0000275  0.001 European POI. Primary amenorrhea. Atrophic ovaries 
15 p.Pro242Leu rs567451602 0.0057 0.001 Paraguay POI. Primary amenorrhea 
16 p.Pro242Leu rs567451602 0.0057 0.001 Paraguay POI. Primary amenorrhea (sister of case 12) 
17 p.Pro242Leu rs567451602 0.0057 0.001 European POI. Primary amenorrhea. Atrophic ovaries 
18 p.Ser267Leu rs368972027 0.000017 0.942 Italian POI. Amenorrhea at 30. Hypoparathyroidism during childhood 
19 p.Val282Ile* - - 0.990 Argentinian POI. Secondary amenorrhea 
20 p.Asp382Asn rs143203270 0.0057 0.986 North African POI. Menarche at 12 yrs; secondary amenorrhea at 14 yrs.  
21 p.Asp382Asn rs143203270 0.0057 0.986 European POI. Primary amenorrhea at 16 yr. Absent pubertal development, 
ovaries not seen by ultrasound 
22 p.Asp382Asn rs143203270 0.0057 0.986 French POI. Menarche at 11 yrs; secondary amenorrhea at 14 yrs 
23 p.Ala416Thr rs201602067 0.0004 0.005 Italian POI. Menarche at 9 yrs; secondary amenorrhea and POI at 38 yrs  
24 p.Ala416Thr rs201602067 0.0004 0.005 European POI. Primary amenorrhea 
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